MedTrace Logo

Ketamine Infusion as Sedative Analgesic in Severe ARDS

NCT04818827 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2021-03-26

No results posted yet for this study

Summary

To evaluate whether ketamine is a safe sedative-analgesic agent to be used in an intensive care unit (ICU) setting as compared to traditionally used agents such as propofol, opioids, and midazolam

Conditions

  • Intensive Care Unit Syndrome
  • Mechanical Ventilation Complication
  • Sedatives and Hypnotics Causing Adverse Effects in Therapeutic Use
  • Delirium

Sponsors & Collaborators

  • Interfaith Medical Center

    lead OTHER

Principal Investigators

  • RAMAKANTH PATA, MD · Interfaith Medical Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-11-30
Completion
2021-02-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04818827 on ClinicalTrials.gov